In a first for North America, a Cleveland Clinic patient has given birth after receiving a transplanted uterus from a deceased donor, a significant advancement in infertility treatment.
There is growing interest both nationally and internationally in uterus transplantation. For now, the procedure is restricted to a small number of academic centers under an experimental protocol.
A recent study takes a closer look at the candidates who were screened for a uterine transplantation clinical trial at Cleveland Clinic.
Bioethicists have been instrumental in identifying ethical issues inherent in this groundbreaking transplant. Careful consideration of all aspects of the multi-stage procedure helps recipients make an informed decision and minimize risk to the recipient and fetus
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Dr. Andreas Tzakis shares how the patient is doing, what the surgery involves, why a deceased-donor uterus was used and why he supports transplantation of a non-vital organ.
Building on a history of transplant and reproductive surgery innovations, Cleveland Clinic performed the nation’s first uterus transplant, paving a multi-step path to potential motherhood for women affected by irreversible uterine infertility.
Trial hopes to show that temporary placement of a donor uterus can allow appropriately selected young women to bear children, a concept proven successful in a small European trial
Uterine transplantation was greeted with skepticism eight or nine years ago. Today the procedure offers hope to women with congenital or surgical absence of the uterus.